SUBSCRIBE
SUBSCRIBE

Synexus Takes on the Challenges of Global Vaccine Trials at World Vaccine Congress

April 11, 2011 | 
1 min read
MANCHESTER, England--(BUSINESS WIRE)--Dr Glynis Neagle, Synexus’ Chief Medical Officer will be discussing the challenges facing global vaccine trials at the World Vaccine Congress in Washington this week.
Events Europe
MORE ON THIS TOPIC
Dorval, Quebec, Canada - September 3, 2021: Novartis Pharmaceuticals Canada Inc. head office building in Dorval, Quebec, Canada. Novartis is a global healthcare company based in Switzerland.
Immunology and inflammation
Novartis Presents New Data From Potential First Targeted Sjögren’s Treatment
October 29, 2025
 · 
3 min read
 · 
Heather McKenzie
Highway in Phoenix, Arizona leading toward downtown at sunset
Cell and Gene Therapy
Meeting on the Mesa Arrives Amid Mixed Signals for Cell and Gene Therapy
October 6, 2025
 · 
5 min read
 · 
Ben Hargreaves
Multiple sclerosis damaged myelin or MS autoimmune disease with healthy nerve with exposed fibre with scarrred cell sheath loss as a 3D illustration.
Multiple sclerosis
Beyond BTK Inhibitors: Next Gen MS Treatments Could Transcend Symptom Management
October 6, 2025
 · 
5 min read
 · 
Ben Hargreaves
Victoria Tower Houses of Parliament Westminster Bridge Night Stars London England. Built in the 1800s, House of Commons and House of Lords.
Government
How the UK’s ‘Credibility Challenge’ Hinders Attempts To Reverse Pharma’s Flight
October 1, 2025
 · 
4 min read
 · 
Nick Paul Taylor